Nous avons rafraîchi notre site web ! Explorez-le, dites-nous ce que vous en pensez, ou revisitez le site archivé.
Save the Date: Join us April 28 - May 2 for the 2027 MDF International Conference in Seattle, Washington!
IMPORTANT: Find all anesthesia guides for individuals and their families and healthcare professionals
Inscrivez-vous à la newsletter mensuelle MyDispatch – pour rester informé(e) des avancées de la recherche

Nicholas Johnson, MD, MSCI, FAAN

11958 West Broad Street, Henrico, VA 23233

Clinic: Short Pump Pavilion

Specialty

Neurology

Community Submission Recommendations

DM1, DM2

Other locations

Ambulatory Care Center

Children's Pavilion

Featured in the Digital Academy

How Common is Myotonic Dystrophy in the United States? Findings from the Recent ...

Published: 24 avril 2020

This presentation will discuss the outcome of the recent study exploring the prevalence of myotonic dystrophy type 1 in the United Stat...

What Comes Next: Preparing for DM Clinical Trials - 2020 Virtual Conference

Published: 5 octobre 2020

With many potential drugs and treatments in development, this session explores the different stages of the clinical trials process

ARTHEx biotech - Meet the DM Drug Developers

Published: 19 juin 2021

Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments

Clinical Trial Readiness Workshop

Published: 28 septembre 2021

Originally presented on September 11th, 2021 as a part of the DM1 & DM2 Tracks at the 2021 Virtual MDF Annual Conference.

Clinical Updates: Cardiac Management, DM Clinical Research Network, and Brain Ma...

Published: 28 septembre 2021

Originally presented on September 11th, 2021 as a part of the Professionals Track at the 2021 Virtual MDF Annual Conference.

Research Dataset Presentations - 2022 MDF Annual Conference

Published: 4 novembre 2022

Suzanne McDermott, PhD, presents, Groups of Signs and Symptoms in adult-onset myotonic dystrophy type 1.

Avidity Biosciences Dec 2022 - Meet the DM Drug Developers

Published: 16 décembre 2022

Each month biotechnology, pharmaceutical and academic partners, large and small

Avidity Biosciences Topline Data - 2023 Meet the DM Drug Developers

Published: 24 mai 2023

Sarah Boyce, Avidity CEO, Dr. Steve Hughes, Avidity CMO

DM Drug Development & Approval Considerations with the FDA - 2023 MDF Annual...

Published: 21 novembre 2023

Gain insight and understanding on the important role the FDA plays in the drug approval process through a presentation from the FDA.

Pharma Day with Euro-DyMA - 2025 MDF Conference

Published: 16 juin 2025

The 5th Edition of Pharma Day was presented in partnership by Euro-DyMA (European Dystrophia Myotonica Association) and the Myotonic Dy...